N-Acetylcysteine for Youth Cannabis Use Disorder
Public ClinicalTrials.gov record NCT03055377. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 12-week randomized, placebo-controlled trial of N-acetylcysteine for cannabis use disorder (CUD) in youth (N=192). Participants will be randomized to double-blind NAC or PBO, yielding two equally-allocated treatment groups. All participants will receive brief weekly cannabis cessation counseling and medication management. The primary efficacy outcome will be the proportion of negative urine cannabinoid tests during the 12-week active treatment, compared between groups.
Study identification
- NCT ID
- NCT03055377
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 192 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 14 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2, 2017
- Primary completion
- Jan 30, 2024
- Completion
- Feb 25, 2024
- Last update posted
- Dec 16, 2024
2017 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29403 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cannabis Use Disorder trials
Other public records listing Cannabis Use Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07787572: Applying Neuromodulation to Boost the Efficacy of Motivational Interviewing Not yet recruiting
- NCT07685964: Pregnenolone for Cannabis Use Disorder and Depression Not yet recruiting
- NCT05453513: The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV Recruiting
- NCT06107062: Longitudinal Outpatient Treatment for Cannabis Use Disorder Recruiting
- NCT07634835: Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder Not yet recruiting
- NCT06878859: Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03055377, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2024 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03055377 live on ClinicalTrials.gov.